Arax Advisory Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Arax Advisory Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8	Closed	-$293	–	1316
2022 Q4	$293	Sell	8 -9	-53%	-$356	﹤0.01%	1220
2022 Q3	$1K	Hold	17	–	–	﹤0.01%	1196
2022 Q2	$1K	Hold	17	–	–	﹤0.01%	1144
2022 Q1	$1K	Sell	17 -2	-11%	-$169	﹤0.01%	1135
2021 Q4	$2K	Buy	+19	New	+$1.82K	﹤0.01%	948

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Arax Advisory Partners's SYNH Position: Q1 2023 in Review

Arax Advisory Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 8 shares — an estimated $293 sold.

Arax Advisory Partners first reported a position in SYNH in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Arax Advisory Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Arax Advisory Partners sold 8 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $293.
Arax Advisory Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Arax Advisory Partners's Syneos Health, Inc. Class A Common Stock position peaked at $2K in Q4 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Arax Advisory Partners's 13F filing for Q1 2023, filed 16 May 2023.